𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P.139 Concurrent chemoradiotherapy withpirarubicin and 5-fluorouracil for resectable oral cancer

✍ Scribed by H. Iguchi; M. Kusuki; A. Nakamura; H. Nishiura; A. Kanazawa; K. Hachiya; H. Yamane


Book ID
117803684
Publisher
Elsevier Science
Year
2005
Weight
255 KB
Volume
1
Category
Article
ISSN
1744-7895

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Weekly 5-fluorouracil plus cisplatin for
✍ Young Joo Lee; Chang Geol Lee; Byoung Chul Cho; Gwi Eon Kim; Hye Jin Choi; Eun C πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 160 KB

## Abstract ## Background. In locally advanced head and neck cancer, concurrent chemoradiotherapy (CRT) with combined 5‐fluorouracil (5‐FU) and cisplatin has increased acute toxicities as well as survival. Once‐weekly chemotherapeutic administration schedule may reduce severe toxicities. Thus, we